wellrank.ai
Sign In

Wegovy vs Zepbound: which one should I ask for and where do I get either online?

ClaudecomparisonCollected Aug 9, 2026, 12:02 UTC

Verbatim response from Claude

Wegovy vs Zepbound: Quick Comparison

The Drugs

Wegovy (semaglutide)

  • GLP-1 receptor agonist
  • Average weight loss: ~15% of body weight
  • Made by Novo Nordisk
  • Weekly injection

Zepbound (tirzepatide)

  • Dual GLP-1 + GIP receptor agonist
  • Average weight loss: ~21% of body weight
  • Made by Eli Lilly
  • Weekly injection
  • Generally considered more effective based on clinical trials

Which to Ask For?

Zepbound has the edge for most people due to higher average weight loss. However, your doctor may prefer Wegovy if you have specific cardiovascular risk factors (it has more heart disease outcome data currently).


Where to Get Either Online

  • Hims & Hers (hims.com) - offers both, telehealth consultation included
  • Ro (ro.co) - popular platform, licensed providers
  • Found (joinfound.com) - focuses specifically on weight management
  • Calibrate - includes coaching program

Important Notes

  • You need a prescription - these services connect you with licensed doctors
  • Insurance coverage varies significantly
  • Currently high demand means supply shortages are possible
  • Costs can be $500-$1,300+/month without insurance

Always consult a real physician about which is right for your health history.

Brands mentioned in this answer

More Wegovy answers

See all Wegovy rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.